Shopping Cart
- Remove All
- Your shopping cart is currently empty
Atumelnant (CRN04894) is a selective and potent MC2R antagonist that inhibits ACTH-stimulated corticosterone secretion in a dose-dependent manner for the study of congenital adrenocortical hyperplasia (CAH) and Cushing's disease (CD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Atumelnant (CRN04894) is a selective and potent MC2R antagonist that inhibits ACTH-stimulated corticosterone secretion in a dose-dependent manner for the study of congenital adrenocortical hyperplasia (CAH) and Cushing's disease (CD). |
Targets&IC50 | MC2R (rat):0.23 nM (KB), MC2R (human):0.34 nM (KB) |
In vitro | Atumelnant is an orally potent MC2R antagonist that inhibits corticosterone secretion induced by adrenocorticotropic hormone (ACTH) stimulation in a rat model. Atumelnant has a binding constant (KB value) of 0.34 nM for human MC2R and 0.23 nM for rat MC2R. [1] |
In vivo | In an ACTH-stimulated male rat model, single oral administration of Atumelnant at 3 mg/kg and 30 mg/kg significantly and dose-dependently reduced corticosterone secretion levels. [1] |
Alias | CRN04894, CRN 04894 |
Molecular Weight | 613.71 |
Formula | C33H42F3N5O3 |
Cas No. | 2392970-97-5 |
Smiles | C(=O)(C1(C(F)(F)F)CCC1)N2C[C@@H](CC)N(CC2)C3=C(C(N[C@H]4C5CCN(C4)CC5)=O)N=C(C=C3)C6=C(OCC)C=CC=C6 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (130.35 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.